During the past decade, Cancer Prevention and Research Institute, ISPO conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Prevention and Research Institute, ISPO" #1 collaborator was "University of Florence" with 3 trials as a collaborator, "Istituto Toscano Tumori" with 2 trials as a collaborator, "Careggi Hospital" with 1 trials as a collaborator, "Local Health Authority Pistoia (ITALY)" with 1 trials as a collaborator and "Ministry of Health, Italy" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Prevention and Research Institute, ISPO" are "Cervical Cancer" (2 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Cancer Prevention and Research Institute, ISPO" in a lesser frequency.

Most popular intervention types in "Cancer Prevention and Research Institute, ISPO" are "Other" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Annual invitation to mammography" (1 trials), "Cervarix®, GlaxoSmithKline" (1 trials), "Cervical ThinPrep sampling" (1 trials), "Invitation to screening" (1 trials) and "Low Dose Computed Tomography" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Prevention and Research Institute, ISPO" are 3 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Cancer Prevention and Research Institute, ISPO". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cancer Prevention and Research Institute, ISPO, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Prevention and Research Institute, ISPO, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".